(Visual loss chronic)
4,454 results
  • Redox-inflammation pathways in ocular disease: Targets for nutritional modulation. [Review]
    Arch Soc Esp Oftalmol (Engl Ed). 2026 May 25; :502581. [Online ahead of print]Kavyasree PKV, Jayadevan K, … Therayil AAS
  • Visual impairment remains a major global health burden caused by diverse ocular diseases, including age-related macular degeneration, diabetic retinopathy, glaucoma, uveitis, and ocular surface disorders. Despite differing etiologies, growing evidence identifies oxidative stress and chronic inflammation as a shared pathogenic axis affecting both anterior and posterior ocular segments. High metabo…
  • An international multidisciplinary consensus statement on laparoscopic liver biopsy. [Journal Article]
    Cell Rep Med. 2026 May 22; :102831. [Online ahead of print]Lei SY, Han Y, … International Obesity Society Working Group on Steatotic Liver DiseaseCR
  • Laparoscopic liver biopsy (LLB) provides a way to obtain liver tissue samples under direct visual inspection of the liver surface. It complements percutaneous liver biopsy (PLB) for complex or high-risk cases where PLB cannot be performed. Clinical practices for LLB vary across centers due to the lack of international standards. To improve the procedural quality and diagnostic efficiency of LLB, …
  • Prospective Real-World Outcomes After Switching to Aflibercept 8 mg in Neovascular Age-Related Macular Degeneration with High Treatment Burden. [Journal Article]
    Ophthalmol Ther. 2026 May 19. [Online ahead of print]Spartalis C, Ullrich M, … Findl OOT
  • CONCLUSIONS: In chronically treated patients with nAMD requiring short re-treatment intervals, switching to aflibercept 8 mg was associated with modest anatomical improvement and stable visual function. A reduction in treatment burden was observed in a subset of patients, although overall durability remained heterogeneous and discontinuation rates were high. A cluster of sterile inflammatory events occurred during off-label aliquoted preparation, highlighting the importance of appropriate drug handling. Careful patient selection and strict adherence to on-label preparation procedures are essential to optimize safety. These findings should be interpreted cautiously given the exploratory design, lack of a comparator group, and high discontinuation rate.